DNA Stock Analysis: Buy, Sell, or Hold?
DNA - Ginkgo Bioworks Holdings, Inc.
$7.33
-0.38 (-4.93%)
▼
5d:
-15.46%
30d:
-8.72%
90d:
-18.56%
WAIT
LOW Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Accumulation
DNA is down 13.7% this week, but smart money is accumulating calls. Top strike: $12 2026-06-18 with 901 OI. Call ratio: 83% View Scanner →
Strength: 10.0/10
Get Alerted When DNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: DNA is down 15.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: DNA is down 15.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: DNA is currently trading at $7.33, which is considered fair relative to its 30-day fair value range of $7.06 to $9.19.
Technical Outlook: Technically, DNA is in a strong uptrend. The price is currently testing key support at $7.26. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+10.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DNA is in a strong uptrend. The price is currently testing key support at $7.26. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+10.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$7.06 -
$9.19
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
Protect Your Profits
Holding DNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading below Wall St target ($8.50)
- WARNING: Recommendation downgraded due to -15.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$7.06 -
$9.19
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$7.27
Resistance Level
$10.64
Current Trend
Strong Uptrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.40
Wall Street Target
$8.50
(+10.2%)
Revenue Growth (YoY)
-49.1%
Profit Margin
-201.0%
Share & Embed Analysis
Last updated: May 18, 2026 2:39 PM ET
Data refreshes hourly during market hours. Next update: 3:39 PM
Data refreshes hourly during market hours. Next update: 3:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Steven P Coen
SELL
324 shares
2026-04-17
Steven P Coen
SELL
33171 shares
2026-04-13
Barry Canton
SELL
124727 shares
2026-04-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 45 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 53 HOLD |
Advanced DNA Option Strategies
Professional options setups generated by AI based on today's DNA price and gamma walls.
